Jeff Yass’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-384,200
| Closed | -$73K | – | 12655 |
|
|
2025
Q3 | $73K | Buy |
384,200
+8,100
| +2% | +$9.71K | ﹤0.01% | 11727 |
|
|
2025
Q2 | $639K | Buy |
+376,100
| New | +$635K | ﹤0.01% | 8599 |
|
|
2024
Q4 | – | Sell |
-15,100
| Closed | -$91.5K | – | 12442 |
|
|
2024
Q3 | $91.5K | Sell |
15,100
-18,000
| -54% | -$98.9K | ﹤0.01% | 11101 |
|
|
2024
Q2 | $174K | Sell |
33,100
-14,000
| -30% | -$89K | ﹤0.01% | 10538 |
|
|
2024
Q1 | $400K | Buy |
47,100
+900
| +2% | +$7.86K | ﹤0.01% | 9034 |
|
|
2023
Q4 | $305K | Buy |
+46,200
| New | +$228K | ﹤0.01% | 9804 |
|
|
2023
Q3 | – | Sell |
-11,600
| Closed | -$31.3K | – | 12238 |
|
|
2023
Q2 | $31.3K | Sell |
11,600
-60,500
| -84% | -$177K | ﹤0.01% | 11503 |
|
|
2023
Q1 | $214K | Buy |
72,100
+55,000
| +322% | +$162K | ﹤0.01% | 10454 |
|
|
2022
Q4 | $43.1K | Buy |
+17,100
| New | +$49.1K | ﹤0.01% | 11468 |
|
Jeff Yass's EPIX Position: Q1 2025 in Review
Jeff Yass sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 17,704 shares — an estimated $31.7K sold.
Jeff Yass first reported a position in EPIX in Q4 2017 and held it in 6 quarters. The position peaked at $296K in Q3 2023. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.
- Jeff Yass reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
- Jeff Yass sold 17,704 ESSA Pharma shares in Q1 2025, an estimated $31.7K.
- Jeff Yass first reported a position in ESSA Pharma in Q4 2017 and held it in 6 quarters.
- Jeff Yass's ESSA Pharma position peaked at $296K in Q3 2023.
- 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.